Pectin in biomedical and drug delivery applications: A review

• Published in: International journal of biological macromolecules Vol. 185; pp. 49 - 65
• Main Authors: Li, De-qiang, Li, Jun, Dong, Hui-lin, Li, Xin, Zhang, Jia-qi, Ramaswamy, Shri, Xu, Feng
• Format: Journal Article
• Language: English
• Published: Elsevier B.V 31.08.2021
• Subjects: Biomedical applications; Composite materials; Drug delivery; Hybrid materials; Modification; Pectin; Modification; Pectin; Drug delivery; Composite materials; Biomedical applications; Hybrid materials
• ISSN: 0141-8130; 1879-0003
• DOI: 10.1016/j.ijbiomac.2021.06.088

Natural macromolecules have attracted increasing attention due to their biocompatibility, low toxicity, and biodegradability. Pectin is one of the few polysaccharides with biomedical activity, consequently a candidate in biomedical and drug delivery Applications. Rhamnogalacturonan-II, a smaller component in pectin, plays a major role in biomedical activities. The ubiquitous presence of hydroxyl and carboxyl groups in pectin contribute to their hydrophilicity and, hence, to the favorable biocompatibility, low toxicity, and biodegradability. However, pure pectin-based materials present undesirable swelling and corrosion properties. The hydrophilic groups, via coordination, electrophilic addition, esterification, transesterification reactions, can contribute to pectin's physicochemical properties. Here the properties, extraction, and modification of pectin, which are fundamental to biomedical and drug delivery applications, are reviewed. Moreover, the synthesis, properties, and performance of pectin-based hybrid materials, composite materials, and emulsions are elaborated. The comprehensive review presented here can provide valuable information on pectin and its biomedical and drug delivery applications.